These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9689595)

  • 1. Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure.
    Vejlstrup NG; Bouloumie A; Boesgaard S; Andersen CB; Nielsen-Kudsk JE; Mortensen SA; Kent JD; Harrison DG; Busse R; Aldershvile J
    J Mol Cell Cardiol; 1998 Jun; 30(6):1215-23. PubMed ID: 9689595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte.
    Wang Y; Guo Y; Zhang SX; Wu WJ; Wang J; Bao W; Bolli R
    J Mol Cell Cardiol; 2002 Jan; 34(1):5-15. PubMed ID: 11812160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of inducible nitric oxide synthase in human heart failure.
    Haywood GA; Tsao PS; von der Leyen HE; Mann MJ; Keeling PJ; Trindade PT; Lewis NP; Byrne CD; Rickenbacher PR; Bishopric NH; Cooke JP; McKenna WJ; Fowler MB
    Circulation; 1996 Mar; 93(6):1087-94. PubMed ID: 8653828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy.
    Satoh M; Nakamura M; Tamura G; Makita S; Segawa I; Tashiro A; Satodate R; Hiramori K
    J Am Coll Cardiol; 1997 Mar; 29(4):716-24. PubMed ID: 9091515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible nitric oxide synthase gene transcription and protein activity in the rat heart during endotoxaemia.
    Robinson NM; Westmore KR; Martin JF; Emson P; Charles IG
    Biochem Biophys Res Commun; 1997 Feb; 231(1):211-6. PubMed ID: 9070251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin-converting enzyme inhibitor therapy.
    Morawietz H; Rohrbach S; Rueckschloss U; Schellenberger E; Hakim K; Zerkowski HR; Kojda G; Darmer D; Holtz J
    Eur J Clin Invest; 2006 Oct; 36(10):705-12. PubMed ID: 16968466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between expression of TNF alpha, iNOS, VEGF mRNA and development of heart failure after experimental myocardial infarction in rats.
    Heba G; Krzemiński T; Porc M; Grzyb J; Dembińska-Kieć A
    J Physiol Pharmacol; 2001 Mar; 52(1):39-52. PubMed ID: 11321512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure.
    Stein B; Eschenhagen T; Rüdiger J; Scholz H; Förstermann U; Gath I
    J Am Coll Cardiol; 1998 Nov; 32(5):1179-86. PubMed ID: 9809923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart.
    Patten RD; Denofrio D; El-Zaru M; Kakkar R; Saunders J; Celestin F; Warner K; Rastegar H; Khabbaz KR; Udelson JE; Konstam MA; Karas RH
    J Am Coll Cardiol; 2005 May; 45(9):1419-24. PubMed ID: 15862412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressed expression of GTP cyclohydrolase I mRNA and accelerated expression of inducible nitric oxide synthase mRNA in endomyocardial biopsy specimens from patients with dilated cardiomyopathy.
    Ohtsuki M; Nomura T; Morimoto S; Hiramitsu S; Uemura A; Kato S; Kato Y; Shiraishi H; Shimokubo J; Yamamoto N; Hishida H
    Clin Chim Acta; 2005 Mar; 353(1-2):103-7. PubMed ID: 15698596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simvastatin and ischemia-reperfusion damage: its effects on apoptotic myocyte death and on the endothelial expression of nitric-oxide synthetase in an experimental model of the isolated rat heart].
    Di Napoli P; Maggi A; Spina R; Barsotti L; Taccardi AA; Stuppia L; Vianale G; Palka G; Barsotti A
    Cardiologia; 1999 Jan; 44(1):69-74. PubMed ID: 10188333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy.
    Francis SE; Holden H; Holt CM; Duff GW
    J Mol Cell Cardiol; 1998 Feb; 30(2):215-23. PubMed ID: 9514998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy.
    Szotowski B; Goldin-Lang P; Antoniak S; Bogdanov VY; Pathirana D; Pauschinger M; Dörner A; Kuehl U; Coupland S; Nemerson Y; Hummel M; Poller W; Hetzer R; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2005 Apr; 45(7):1081-9. PubMed ID: 15808768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE2 gene expression is up-regulated in the human failing heart.
    Goulter AB; Goddard MJ; Allen JC; Clark KL
    BMC Med; 2004 May; 2():19. PubMed ID: 15151696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence imaging microscopy of cellular markers in ischemic vs non-ischemic cardiomyopathy after left ventricular unloading.
    Bick RJ; Bagwell SH; Jones CE; Poindexter BJ; Buja LM; Youker KA; Grigore A; Clubb F; Radovancevic B; Frazier OH
    J Heart Lung Transplant; 2005 Apr; 24(4):454-61. PubMed ID: 15797748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloendopeptidase inhibition regulates phosphorylation of p38-mitogen-activated protein kinase and nitric oxide synthase in heart after endotoxemia.
    Gupta A; Sharma AC
    Shock; 2003 Oct; 20(4):375-81. PubMed ID: 14501953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease.
    de Belder AJ; Radomski MW; Why HJ; Richardson PJ; Martin JF
    Br Heart J; 1995 Oct; 74(4):426-30. PubMed ID: 7488459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible NO synthase expression in endomyocardial biopsies after heart transplantation in relation to the postoperative course.
    Koch A; Burgschweiger A; Herpel E; Sack FU; Schirmacher P; Szabo GB; Karck M; Schnabel PA
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):639-43. PubMed ID: 17689088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA).
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Grisorio B; Pellicelli A; Barbarini G
    Circulation; 1999 Aug; 100(9):933-9. PubMed ID: 10468523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.